Literature DB >> 16574952

Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL.

Wim J E Tissing1, Jules P P Meijerink, Bas Brinkhof, Mathilde J C Broekhuis, Renee X Menezes, Monique L den Boer, Rob Pieters.   

Abstract

Glucocorticoid (GC) resistance is an adverse prognostic factor in childhood acute lymphoblastic leukemia (ALL), but little is known about causes of GC resistance. Up-regulation of the glucocorticoid receptor (GR) has been suggested as an essential step to the induction of apoptosis in leukemic cells. In this study we investigated whether baseline mRNA expression levels of the 5 different GR promoter transcripts (1A1, 1A2, 1A3, 1B, and 1C) or differences in the degree of regulation of the GR or GR promoter transcripts upon GC exposure are related to GC resistance. Therefore, mRNA levels of the 5 GR promoter transcripts and of the GR were measured by quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR; Taqman) technology in primary ALL cells prior to and after 3, 8, and 24 hours of prednisolone exposure. GR expression is induced upon GC exposure in primary ALL patient samples, which is opposite to what is found in tissues in which GCs do not induce apoptosis. GC resistance in childhood ALL cannot be attributed to an inability of resistant cells to up-regulate the expression of the GR upon GC exposure, nor to differences in GR promoter usage (at baseline and upon GC exposure).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574952     DOI: 10.1182/blood-2006-01-0261

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia.

Authors:  Jason R Schwartz; Purvaba J Sarvaiya; Wayne V Vedeckis
Journal:  Mol Cell Endocrinol       Date:  2010-02-17       Impact factor: 4.102

2.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

3.  Gene set enrichment analysis unveils the mechanism for the phosphodiesterase 4B control of glucocorticoid response in B-cell lymphoma.

Authors:  Sang-Woo Kim; Deepak Rai; Ricardo C T Aguiar
Journal:  Clin Cancer Res       Date:  2011-07-08       Impact factor: 12.531

4.  Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes.

Authors:  Lindsay K Smith; John A Cidlowski
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

5.  Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance.

Authors:  Laura Bonapace; Beat C Bornhauser; Maike Schmitz; Gunnar Cario; Urs Ziegler; Felix K Niggli; Beat W Schäfer; Martin Schrappe; Martin Stanulla; Jean-Pierre Bourquin
Journal:  J Clin Invest       Date:  2010-04       Impact factor: 14.808

6.  Use of recombinant cell-permeable small peptides to modulate glucocorticoid sensitivity of acute lymphoblastic leukemia cells.

Authors:  Chuan-dong Geng; Wayne V Vedeckis
Journal:  Biochemistry       Date:  2010-10-19       Impact factor: 3.162

7.  Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.

Authors:  L Olsson; A Castor; M Behrendtz; A Biloglav; E Forestier; K Paulsson; B Johansson
Journal:  Leukemia       Date:  2013-07-04       Impact factor: 11.528

8.  Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis.

Authors:  Ling Gu; Chenyan Zhou; Huajun Liu; Ju Gao; Qiang Li; Dezhi Mu; Zhigui Ma
Journal:  J Exp Clin Cancer Res       Date:  2010-11-18

Review 9.  NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia.

Authors:  P J Real; A A Ferrando
Journal:  Leukemia       Date:  2009-04-09       Impact factor: 11.528

10.  Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.

Authors:  Esther Hulleman; Karin M Kazemier; Amy Holleman; David J VanderWeele; Charles M Rudin; Mathilde J C Broekhuis; William E Evans; Rob Pieters; Monique L Den Boer
Journal:  Blood       Date:  2008-10-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.